Ausbildung und Werdegang

 

 

2018 -

Senior Advisor, Partners Group (Zug, Switzerland)

 

2008 -

Founder, medical director, chief surgeon Vista Alpina eye center, Visp/Sierre, Switzerland

 

2005 - 2012

Training in ophthalmology and ophthalmic surgery: Lucerne cantonal eye clinic (PD I. Schipper), Inselspital Berne eye clinic (Prof. S. Wolf), Dr. Agarwal eye hospital (Chenai, India), Vista Alpina eye clinic (Switzerland)

 

2001 - 2005

Global Marketing Manager, and Global Medical Manager, Cardiovascular franchise, Novartis International, Basel, Switzerland and Tokyo, Japan

 

1999 - 2001

Medical advisor, Cardiovascular, Pfizer, Belgium

 

1998 - 2000

Master of Business Administration (executive MBA, Vlerick Leuven-Ghent Management School, Belgium

 

1997 - 1999

Head of clinical studies, Therabel Pharma, Belgium

 

1997 - 1998

Master in pharmaceutical medicine, University of Brussels, Belgium

 

1996 - 1997

Cardiology, University Hospital "Jolimont”, La Louvière, Belgium

 

1989 - 1996

Medical School, University of Gent, Belgium

Disclaimer:

Augenzentrum Vista Alpina AG und die von dem Augenzentrum Vista Alpina erbrachten Leistungen stehen in keiner rechtlichen oder tatsächlichen Verbindung zur Vista Klinik AG, Laser Vista AG, Vista Klinik Net AG oder Vista Diagnostics AG.

Mitgliedschaften

 

Walliser Ärzteverband (WÄV)

 

Verbindung der Schweizer Ärtinnen und Ärzte (FMH)

 

Schweizerische Ophthalmologische Gesellschaft (SOG)

 

European Society of Cataract and Refractive Surgeons (ECRS)

 

American Academy of Ophthalmology (AAO)

 

SAC Zermatt

Auszeichnungen

 

2014

Best of the Best Presentation at the ESCRS (European Society of Cataract and Refractive Surgery) September 17, 2014, London, UK.

K. Vandekerckhove.

Ankoris: a new toric IOL with insufficient rotational stability after cataract surgery

 

1995

Posterpreis am Symposium der Belgian Association of Clinical Biology (Erstautor): „De immuunstatus voor rubella en toxoplasma bij meisjes tussen 12 en 18 jaar“

 

1989

Gewinner der flämischen Chemie-Olympiade und Teilnahme an der internationalen Chemie-Olympiade in Halle, ehemalige DDR

Kongressveröffentlichungen

 

2014

Swiss Society of Ophthalmology, Annual Meeting, August 27-30, 2014, Interlaken, Switzerland.

K. Vandekerckhove.

Aflibercept versus Ranibizumab in diabetic macular edema.

 

2014

Swiss Society of Ophthalmology, Annual Meeting, August 27-30, 2014, Interlaken, Switzerland.

K. Vandekerckhove.

Aflibercept in eyes with incomplete response to Ranibizumab in AMD.

 

2014

EURETINA, 14th International Congress, September 11 – 14, 2014, London, UK.

K. Vandekerckhove.

Aflibercept versus ranibizumab in diabetic macular edema.

 

2013

ESASO European School for Advanced Studies in Opthalmology, 13th International AMD and Retina Congress, October 25 – 26, 2013, Dublin, Ireland.

K. Vandekerckhove.

Aflibercept Therapy For Exudative Age-Related Macular Degeneration In Eyes With Incomplete Reponse To Ranibizumab.

 

2012

Swiss Society of Ophthalmology, Annual Meeting, August 29 - September 1, 2012, Fribourg, Switzerland.

K. Vandekerckhove.

Ranibizumab und Retinopathia centralis serosa (RCS).

 

2008

ARVO The Association for Research in Vision and Ophthalmology, 2008.

Barbara Kloeckener-Gruissem, Gudrun Nürnberg, John Neidhardt, Christina Zeitz, Stephan Labs, Daniel Schorderet, Francis Munier, Anthony Moore,  Shomi Bhattacharya, Kristof Vandekerckhove, Peter Nürnberg, and Wolfgang Berger.

Genetic mapping and identification of a stop mutation in a monocarboxylate transporter: association with juvenile cataract, microcornea and renal glucosuria.

 

2006

Swiss Society of Ophthalmology, Annual Meeting, September 6-9, 2006, Lugano, Switzerland.

K. Vandekerckhove and O. Job.

NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) after a long airplane-flight in a young adult.

 

2006

Swiss Society of Ophthalmology, Annual Meeting, September 6-9, 2006, Lugano, Switzerland.

K. Vandekerckhove, A.Lange and I. Schipper.

Juvenile cataract associated with micro-cornea and isolated glucosuria: a new syndrome.

 

2001

14th Cardiology Update, February 12-16, 2001, Davos, Switzerland.

K Vandekerckhove, O Gurné, P Block, G Berkenboom, JM Boeynaems.

BIMED, Biological Markers of Endothelial Dysfunction.

 

2001

14th Cardiology Update, February 12-16, 2001, Davos, Switzerland.

P Block, JL Rouleau, W van Gilst, Ch Bauters, W Warnica, K Vandekerckhove

IMAGINE, Ischemic Management  with Accupril post bypass Graft via Inhibition of converting Enzyme.

 

1997

International Symposium on nitric oxide, basic and clinical pharmacology, Odense, Denmark, June 9-10, 1997.

R.A. Lefebvre and K. Vandekerckhove.

Influence of NO donors and long-term electrical stimulation on nitrergic relaxations in the pig gastric fundus.

 

1997

44th Annual Meeting of the Society of Nuclear Medicine, San Antonio, Texas, Jun 1-5, 1997.

C. De Sadeleer, M. Simons, C. Van de Wiele, H. Thierens, K. Vandekerckhove, and R.A. Dierckx.

Technetium-99m HDP scintigraphic follow-up of patients treated for primary malignant bone tumor by bone autograft after external high-dose radiation therapy.

 

1995

Symposium of the Belgian Association of Clinical Biology, Luik, October 14th 1995.

Vandekerckhove K., Verstraete A., Leroux-Roels G.

De immuunstatus voor rubella en toxoplasma bij meisjes tussen 12 en 18 jaar.

Publikationen

 

2018

Vandekerckhove K., Rotational Stability of Monofocal and Trifocal Intraocular Toric Lenses With Identical Design and Material but Different Surface Treatment, J Refract Surg. 2018;34(2):84-91

 

2015

Vandekerckhove K., Aflibercept versus ranibizumab for treating persistent diabetic macular oedema, International Ophthalmology 2015; 35(4):603-9

 

2009

Lange AP, Vandekerckhove K., Becht C, Zakrzewski PA, Schmid MK.
Spontaneous closure of a traumatic macular hole.

Klin Monatsbl Augenheilkd. 2009 Apr ; 226(4):359-60

 

2008

B. Kloeckener-Gruissem*, K. Vandekerckhove* et al (* first authors, equal contribution)

Mutation of the solute carrier SLC16A12 associates with a novel syndrome combining autosomal dominant juvenile cataract with microcornea and glucosuria.

American Journal of Human Genetic 2008

 

2007

Vandekerckhove K., Lange A. P., Herzog D. C. J., Schipper I.

Juvenile cataract associated with micro-cornea and glucosuria: a new syndrome. Klin Monatsbl Augenh 2007; 224:344-346

 

1998

R.A. Lefebvre and K. Vandekerckhove.

Influence of nitroglycerine and long-term electrical stimulation on nitrergic relaxations in the pig gastric fundus, British Journal of Pharmacology, 123, 143-149, (1998).

 

1998

Ginsberg F., Joos E., Géczy J., Bruhwyler J., Vandekerckhove K. and Famaey JP.

A pilot randomized placebo-controlled study of pirlindole in the treatment of primary fibromyalgia, Journal of Musculoskeletal Pain, 6(2), 5-17, (1998).

 

1998

Famaey J.P., Vandekerckhove K., Géczy J. and Bruhwyler J.

A large open-label trial of nimesulide in patients with osteoarticular conditions treated in a general practice setting, Current therapeutic Research, 59(7), 467-482, (1998).

 

1998

Famaey J.P., Bruhwyler J., Géczy J., Vandekerckhove K. and Appelboom T.

Open controlled randomized multicenter comparison of nimesulide and diclofenac in the treatment of subacute and chronic low back pain, Journal of Clinical Research, 1, 219-238, (1998).

 

1997

Bruhwyler J., Monseu M-J., Vandekerckhove K. and Géczy J.

Pirlindole, a reversible and specific monoamine oxidase A inhibitor: A retrospective evaluation of its clinical antidepressant profile,

European Journal of Clinical Research, 9, 225-245, (1997).

 

1997

Braeckman J., Bruhwyler J., Vandekerckhove K. & Géczy J.

Efficacy and safety of the extract of Serenoa repens in the treatment of benign prostatic hyperplasia: therapeutic equivalence between twice and once daily dosage forms, Phytotherapy Research, Vol. 11, 558-563, (1997).

 

1996

Vandekerckhove K. , Verstraete A., Leroux-Roels G.

Immunity against toxoplasma and rubella in girls between 12 and 18 years old.

Acta Clin. Belg., 1996 (abstract).

 

1996

Vandekerckhove K., Verstraete A., Leroux-Roels G.

De immuunstatus voor rubella en toxoplasma bij meisjes tussen 12 en 18 jaar.

Tijdschr. Geneesk., 1996; 52 : 319-323

Vorträge

 

Über 100 Vorträge an Kongressen im In- und Ausland, für (Augen-) Ärzte, für Optiker, für Apotheker und für Patienten.